A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture
Nephrology · 2025
DOI: 10.1111/nep.70010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nephrology, 2025. Verfasst von Toshiki Kano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Nerima Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome, Mutation, Femoral Neck Fractures, Complement Factor I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Atypical hemolytic uremic syndrome is a thrombotic microangiopathy caused by the abnormal activation of the alternative complement pathway. Mutations in complement‐related genes and autoantibodies against complement regulators are involved in the pathogenesis of this condition; the frequency of, and prognosis of patients harbouring, each genetic mutation varies based on the region and race. Complement factor I ( CFI ) mutations have been observed in 4%–8% of cases in Europe; however, they have not yet been reported in Japan. We present the first Japanese case of atypical hemolytic uremic syndrome in a patient harbouring a CFI mutation. An 83‐year‐old female patient presented with severe acute kidney injury, thrombocytopenia, and hemolytic anaemia following a femoral neck fracture. Plasma exchange and haemodialysis were initiated, resulting in improved kidney function and platelet count. However, the platelet count decreased when plasma exchange was discontinued. Therefore, we administered ravulizumab, an anti‐complement 5 monoclonal antibody, which led to the maintenance of stable kidney function and platelet count. Genetic analysis revealed a CFI mutation, and the patient was treated with ravulizumab for 2 years without relapse. Individuals diagnosed with atypical hemolytic uremic syndrome harbouring CFI mutations experience poor outcomes, including low rates of remission, high rates of mortality, and progression to end‐stage kidney disease. Our case serves as a crucial example demonstrating how prompt identification and appropriate management can lead to better patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Juntendo University Nerima Hospital, Tokyo, Japan.
- Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
ORCID-Profile: Toshiki Kano, Hiroaki Io
Zitieren
APA
Kano, T., Io, H., Sasaki, Y., Muto, M., Muto, S., Ogiwara, K., Ikeda, A., Iwasaki, H., & Suzuki, Y. (2025). A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture. Nephrology. https://doi.org/10.1111/nep.70010
Vancouver
Kano T, Io H, Sasaki Y, Muto M, Muto S, Ogiwara K, et al. A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture. Nephrology. 2025. doi:10.1111/nep.70010
BibTeX
@article{Kano2025,
author = {Kano, Toshiki and Io, Hiroaki and Sasaki, Yu and Muto, Masahiro and Muto, Sayaka and Ogiwara, Kei and Ikeda, Arisa and Iwasaki, Hiroyuki and Suzuki, Yusuke},
title = {A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture},
journal = {Nephrology},
year = {2025},
doi = {10.1111/nep.70010}
}
EUVIMED